Elder Pharmaceuticals

Last updated

Elder Pharmaceuticals
Company type Public
  • BSE: 532322
  • NSE: ELDERPHARM
Industry Pharmaceuticals, Drugs & healthcare
Founded1989;35 years ago (1989) [1]
FounderJagdish Saxena
Headquarters
Mumbai, Maharashtra [2]
,
India
ProductsMedicines and Vaccines
RevenueIncrease2.svg ₹ 16,743 million (2013) [3]
Increase2.svg ₹ 823 million (2013) [3]
Increase2.svg ₹ 937 million (2013) [3]
Total assets Increase2.svg ₹ 24,924 million (2013) [3]
Total equity Increase2.svg ₹ 7,691 million (2013) [3]
Number of employees
4300 [4]
Subsidiaries NeutraHealth, [5] Elvista [6]
Website https://elderpharma.com/

Elder Pharmaceuticals Ltd is a pharmaceutical company headquartered in Mumbai, Maharashtra. [7] Its main activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. Its largest presence in three therapeutic segments, Women's Healthcare, Wound Care and Nutraceuticals. It has 6 manufacturing plants in India & 1 in Nepal. It manufacture various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments. [8]

Contents

History

In 1989, Jagdish Saxena formed Elder Pharmaceuticals in Mumbai when he lost his job due to the shut down of the pharma division of a company for which he was working. The first manufacturing plant was set up in 1989 at Nerul. It was listed on Bombay Stock Exchange and National Stock Exchange in 2000. [9]

In 2010, the company acquired the UK-based supplements company NeutraHealth for £12.2 million. [10]

On 13 December 2013, Torrent Pharmaceuticals signed a definitive deal to acquire Elder Pharmaceuticals' branded domestic formulations business in India and Nepal for ₹2,000 crore. [11] Even after the sale, Elder Pharmaceuticals faced a debt crisis. [12] In 2016, the company was delisted from the stock exchanges on account of non-compliances. [13]

In October 2013, founder Jagdish Saxena died. [14] In October 2017, the MD Alok Saxena died at the age of 52. [15] The promoter group was later led by Jagdish Saxena's second son Anuj Saxena, a former TV actor, and daughter Shalini Saxena Kumar, an entrepreneur. [16]

Related Research Articles

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and other medical conditions.

<span class="mw-page-title-main">Dilip Shanghvi</span> Indian Businessman

Dilip Shanghvi is an Indian billionaire businessman and one of the country's richest people. He founded Sun Pharmaceuticals. The Government of India awarded him the civilian honour of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Century Pharmaceuticals</span> Indian pharmaceutical company

Century Pharmaceuticals Ltd. is an Indian pharmaceutical company, founded in 1982 in Vadodara, Gujarat, India.

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed briefly by US-based Pfizer. Teva regained its market leader position once Pfizer spun off its generic drug division in a merger with Mylan, forming the new company Viatris at the end of 2020. Overall, Teva is the 18th largest pharmaceutical company in the world.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, owned by the Rs 37,000 crore Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe.

Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973.

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company is a major producer of HIV antivirals, as well as gynaecology and blood therapeutic drugs.

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

AMRI is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

<span class="mw-page-title-main">Piramal Group</span> Indian conglomerate

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.

<span class="mw-page-title-main">Alkem Laboratories</span> Indian pharmaceutical company

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology. veterinary APIs and agro chemicals. The company was founded in 2005 by Dr. Satyanarayana Chava.

<span class="mw-page-title-main">Divi's Laboratories</span> Indian pharmaceutical company

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.

The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities. Ahmedabad and Vadodara are considered as pharmaceutical hubs as there are many big and small pharma companies established in these cities.

References

  1. ↑ "Elder : Corporate - Introduction". Elderindia.com. Archived from the original on 29 December 2010. Retrieved 8 January 2011.
  2. ↑ "Elder Contact". Elderindia.com. Archived from the original on 16 December 2010. Retrieved 8 January 2011.
  3. 1 2 3 4 5 "BSE Plus". moneycontrol.com. Retrieved 21 December 2020.
  4. ↑ "Elder Pharma hiring 1,000 sales staff to tap India's rural market, pharma jobs in India Elder Pharma employment | DWS Pill Scribe". Dancewithshadows.com. 19 April 2010. Archived from the original on 26 April 2010. Retrieved 8 January 2011.
  5. ↑ "Elder Pharma to buy UK's NeutraHealth for $19.1 mn - Corporate News". Mint. 16 September 2010. Retrieved 8 January 2011.
  6. ↑ "Elder Pharma backs out of Ghana venture - Money". Daily News and Analysis. 15 January 2010. Retrieved 8 January 2011.
  7. ↑ "Elder Pharma gets Japanese approval for API facility". Business Standard India. Business-standard.com. Press Trust of India. 3 January 2011. Retrieved 8 January 2011.
  8. ↑ "How Elder Pharma was born". Rediff.com. 31 July 2004. Retrieved 8 January 2011.
  9. ↑ "Elder: Corporate History /Corporate Background". Elderindia.com. Archived from the original on 16 December 2010. Retrieved 8 January 2011.
  10. ↑ "NeutraHealth to be bought by India's Elder Pharma". Reuters. 16 September 2010. Retrieved 31 August 2023.
  11. ↑ "Torrent Pharma to buy Elder's India business for Rs 2,000 cr". Business Standard. Retrieved 31 August 2023.
  12. ↑ Rebello, Joel; Balakrishnan, Reghu (11 September 2015). "Elder Pharma to sell assets to clear debt". mint. Retrieved 31 August 2023.
  13. ↑ "Elder Pharmaceuticals drops after NSE announces trading suspension". Business Standard. Retrieved 31 August 2023.
  14. ↑ "The Visionary Entrepreneur of Elder Pharma late Jagdish Saxena was a man of emotions & a compassionate leader. Remembering the leader! – Indian Affairs". 6 May 2015.
  15. ↑ Balakrishnan, Reghu (10 October 2013). "Elder Pharma CMD Saxena passes away". Business Standard India– via Business Standard.
  16. ↑ "Elder Pharma MD passes away, shadow over company intensifies". BusinessLine. 23 October 2017. Retrieved 31 August 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.